Ledipasvir and Sofosbuvir Tablets

Next > >

<< Previous

Send Inquiry

Product Code : 06

Price And Quantity

Minimum Order Quantity
1 to 1000000
Unit of Measure
Unit/Units

Product Specifications

Application
Control Virus
Formulations Type
Chemical Drug

Formulations Form
Tablets
Gender/Age Group
Adult

Product Description

We are a well acclaimed pharmaceutical company, engaged in supplying the best stock of Hepcinat LP. The medicine is specially formulated using an excellent combination of two anti- viral medications, viz Ledipasvir and Sofosbuvir. The Hepcinat Lp is widely used in the treatment of chronic hepatitis C virus (CHCV) infection genotype 1. It is basically a prescription medicine which contains Ledipasvir, a viral NS5A inhibitor and Sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase.

Key Points:

A cure rate between 94% and 99%
Prevents multiplication of hepatitis C virus infection
It weakens the virus and inhibits its reproduction and replication

Trade Information

Payment Terms
Cash on Delivery (COD), Cash Advance (CA), Delivery Point (DP), Western Union
Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa